Treatment options for Lambert-Eaton myasthenic syndrome

Author(s):
Sonderen, A. van; Wirtz, P.W.; Verschuuren, J.J.G.M. (0000-0002-4572-1501); Titulaer, M.J.
Published
2014
Publication type
Article / Letter to editor
3,4-diaminopyridineimmunosuppressionLambert-Eaton myasthenic syndromepyridostigminesmall-cell lung cancer
Date issued
2014-02-28
Language
English
Is part of
Expert opinion on orphan drugs (2014), Vol. 2, no. 2, p. 159-167
hdl
1887/104026
doi
10.1517/21678707.2014.872559